Q4 2023 · 13F-HR
Data Collective IV GP, LLCholdings as filed
Filed 2024-02-14 · accession 0001104659-24-022997
$120.9M
Reported value
5
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 75629V104 | RXRX | Recursion Pharmaceuticals, Inc. | $58.6M | 48.5% | 5,941,120 | Common | SOLE |
| 30049H102 | EVLV | Evolv Technologies Holdings, Inc. | $45.7M | 37.8% | 9,681,281 | Common | SOLE |
| 773122106 | — | Rocket Lab USA, Inc. | $16.2M | 13.4% | 2,929,350 | Common | SOLE |
| 60255C885 | BRD1EUR | Mind Medicine (MindMed) Inc. | $367,281 | 0.30% | 100,350 | Common | SOLE |
| G76279101 | ROIV | Roivant Sciences Ltd. | $43,516 | 0.04% | 3,875 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.